Azole-resistant central nervous system aspergillosis.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 19272019.
- Also identified by DOI 10.1086/597465.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Three patients with central nervous system aspergillosis due to azole-resistant Aspergillus fumigatus (associated with a leucine substitution for histidine at codon 98 [L98H] and a 34-base pair repeat in tandem in the promoter region) are described. The patients were treated with combination therapy or with polyenes, but all patients died. Azole resistance significantly complicates the management of aspergillosis by delaying the initiation of adequate therapy and because effective alternative antifungal drugs are lacking.
Medical subject headings
- Aspergillus fumigatus
- Azoles
- Central Nervous System Infections
- Drug Resistance, Fungal
- Neuroaspergillosis